KR20220044288A - 누액 분비 촉진용 안과 조성물 - Google Patents

누액 분비 촉진용 안과 조성물 Download PDF

Info

Publication number
KR20220044288A
KR20220044288A KR1020227005681A KR20227005681A KR20220044288A KR 20220044288 A KR20220044288 A KR 20220044288A KR 1020227005681 A KR1020227005681 A KR 1020227005681A KR 20227005681 A KR20227005681 A KR 20227005681A KR 20220044288 A KR20220044288 A KR 20220044288A
Authority
KR
South Korea
Prior art keywords
ophthalmic composition
delgocitinib
salt
lacrimal
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227005681A
Other languages
English (en)
Korean (ko)
Inventor
요시히로 다카이
다카히로 구로세
Original Assignee
로토 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로토 세이야쿠 가부시키가이샤 filed Critical 로토 세이야쿠 가부시키가이샤
Publication of KR20220044288A publication Critical patent/KR20220044288A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227005681A 2019-08-07 2020-08-06 누액 분비 촉진용 안과 조성물 Pending KR20220044288A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019145670 2019-08-07
JPJP-P-2019-145670 2019-08-07
JP2019239605 2019-12-27
JPJP-P-2019-239605 2019-12-27
PCT/JP2020/030231 WO2021025129A1 (ja) 2019-08-07 2020-08-06 涙液分泌促進用眼科組成物

Publications (1)

Publication Number Publication Date
KR20220044288A true KR20220044288A (ko) 2022-04-07

Family

ID=74503644

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227005681A Pending KR20220044288A (ko) 2019-08-07 2020-08-06 누액 분비 촉진용 안과 조성물

Country Status (7)

Country Link
US (1) US20220280515A1 (https=)
EP (1) EP4011450A4 (https=)
JP (2) JP7597714B2 (https=)
KR (1) KR20220044288A (https=)
CN (2) CN114173788A (https=)
TW (1) TW202120094A (https=)
WO (1) WO2021025129A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
AU2021318236A1 (en) * 2020-07-30 2023-03-09 Rohto Pharmaceutical Co., Ltd. Aqueous composition
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition
JP2025014078A (ja) * 2021-11-30 2025-01-29 興和株式会社 新規ニコチンアミド化合物及びその用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017006968A1 (ja) 2015-07-07 2017-01-12 日本たばこ産業株式会社 ７Ｈ－ピロロ［２，３－ｄ］ピリミジン誘導体の製造方法及びその中間体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541426B2 (en) * 2007-07-11 2013-09-24 Pfizer Inc. Pharmaceutical compositions and methods of treating dry eye disorders
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
KR102306276B1 (ko) * 2013-10-21 2021-09-30 니뽄 다바코 산교 가부시키가이샤 안질환의 치료제 또는 예방제
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
CA3044771A1 (en) * 2016-12-21 2018-06-28 Japan Tobacco Inc. Crystalline forms of a janus kinase inhibitor
JP7722931B2 (ja) * 2019-12-27 2025-08-13 ロート製薬株式会社 水性組成物
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017006968A1 (ja) 2015-07-07 2017-01-12 日本たばこ産業株式会社 ７Ｈ－ピロロ［２，３－ｄ］ピリミジン誘導体の製造方法及びその中間体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
디쿠아스 점안액 3% 첨부문서(2017년 11월 개정)

Also Published As

Publication number Publication date
JP2025019313A (ja) 2025-02-06
TW202120094A (zh) 2021-06-01
EP4011450A4 (en) 2023-08-09
CN118903144A (zh) 2024-11-08
WO2021025129A1 (ja) 2021-02-11
EP4011450A1 (en) 2022-06-15
CN114173788A (zh) 2022-03-11
US20220280515A1 (en) 2022-09-08
JP7597714B2 (ja) 2024-12-10
JPWO2021025129A1 (https=) 2021-02-11

Similar Documents

Publication Publication Date Title
KR20220044288A (ko) 누액 분비 촉진용 안과 조성물
JP6886878B2 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
JP2022003099A (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP4482726B2 (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
KR20210105916A (ko) 우루소데옥시콜산을 함유하는 노시의 치료 또는 예방제
US10973758B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
US10688113B2 (en) Methods of treating eye pain with aminophosphinic derivatives
WO2016171152A1 (ja) 角膜障害の治療剤、改善剤または予防剤
JP4933897B2 (ja) 眼内移行性促進水性点眼剤
JP6934581B2 (ja) エピナスチン又はその塩を含有する水性医薬組成物
BR112021000240A2 (pt) Composições oftálmicas que contêm uma prostamida que libera óxido nítrico
JP2012250951A (ja) アデノシン誘導体とプロスタグランジン類とβ受容体遮断薬の組合せ剤
JP7628098B2 (ja) エピナスチン又はその塩を含有する花粉破裂抑制剤
US20140228338A1 (en) Topical ocular analgesic agents
HK40066213A (zh) 泪液分泌促进用眼科组合物
RU2836815C1 (ru) Офтальмологические композиции для местного применения на ксантановой основе с сокращенным режимом дозирования
US20250312349A1 (en) Composition and methods of treating intracellular pathogen infection
JP2012250949A (ja) アデノシン誘導体と炭酸脱水酵素阻害剤とβ受容体遮断薬の組合せ剤
JP2016034936A (ja) 角膜上皮障害治療剤の組み合わせ
JP2012250950A (ja) アデノシン誘導体とプロスタグランジン類の組合せ剤
US20110092509A1 (en) Pharmaceutical Composition for Prevention or Treatment of Disease Associated with Tear Reduction

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902